Statement on transdermal contraception as an underused option for unmet needs in contraception: the importance of structured counselling
Introduction Evra® (Gedeon Richter Plc., Budapest, Hungary), introduced nearly 20 years ago, was the first transdermal contraceptive patch designed to deliver two hormones. The Evra® patch has high contraceptive efficacy with an overall Pearl Index of 0.90 (95% CI, 0.44–1.35) 1. Studies have shown that the use of the Evra® patch is associated with improved […]